These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 24650314)

  • 1. Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.
    Ong DS; Scherrer-Crosbie M; Coelho-Filho O; Francis SA; Neilan TG
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):487-97. PubMed ID: 24650314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced imaging modalities to detect cardiotoxicity.
    Awadalla M; Hassan MZO; Alvi RM; Neilan TG
    Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity: cisplatin and long-term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiotoxicity of cancer chemotherapy: implications for children.
    Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
    Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer agents and cardiotoxicity.
    Ng R; Better N; Green MD
    Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity of cancer therapy.
    Floyd JD; Nguyen DT; Lobins RL; Bashir Q; Doll DC; Perry MC
    J Clin Oncol; 2005 Oct; 23(30):7685-96. PubMed ID: 16234530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biomarkers in chemotherapy-induced cardiotoxicity.
    Cardinale D; Sandri MT
    Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular toxicity of biologic agents for cancer therapy.
    Bhave M; Akhter N; Rosen ST
    Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
    Garg V; Vorobiof G
    Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicity.
    Bhave M; Shah AN; Akhter N; Rosen ST
    Curr Opin Oncol; 2014 Nov; 26(6):590-9. PubMed ID: 25233068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular complications in oncology patients].
    Suzuki Y; Tokuda Y
    Nihon Rinsho; 2003 Jun; 61(6):984-9. PubMed ID: 12806947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic imaging methods of cardiac dysfunction caused by cardiotoxicity of oncological therapy].
    Lelakowska-Pieła M; Słowik A; Kozynacka A; Panek M; Konduracka E; Nessler J
    Pol Merkur Lekarski; 2016 Jan; 40(235):36-9. PubMed ID: 26891435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity of cancer therapy].
    Marek J; Linhart A; Rucklová Z; Haber J; Korínek J
    Vnitr Lek; 2011 May; 57(5):472-84. PubMed ID: 21695928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the art review: Chemotherapy-induced cardiotoxicity in children.
    Loar RW; Noel CV; Tunuguntla H; Colquitt JL; Pignatelli RH
    Congenit Heart Dis; 2018 Jan; 13(1):5-15. PubMed ID: 29226596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of cardiovascular complications secondary to medical treatment of cancer].
    Banke A; Polk A; Nielsen D; Videbæk L; Overgaard U; Fosbøl EL; Vaage-Nielsen M; Nielsen KM; Schou M
    Ugeskr Laeger; 2018 Feb; 180(7):. PubMed ID: 29465031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.